ערך בספרים למניה: Biomerica, Inc. (BMRA)

Biomerica, Inc. (BMRA) ensures diversification through the supply of gastrointestinal diagnostics to clinics in Europe and the US. On GURU.Markets, the book value per share clearly demonstrates the capitalization, where the current figure is 0.79. Business scalability is based on the high-margin sale of consumable systems. Growth in the retail segment of IBS tests serves as the primary driver, despite significant R&D expenditures.

This indicator reflects the residual capital per share, allowing for the determination of the real value of assets net of liabilities and the identification of business degradation risks. Amid severe pricing pressure in the rapid test sector and the dependence of Biomerica, Inc. (BMRA) on clinic procurement terms, the calculated book value per share helps distinguish a temporary downturn from the systemic erosion of equity.